⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 7, 2020EurosurveillanceOpen Access

Coronavirus disease (COVID-19) – impact on vaccine preventable diseases

Daniel Hungerford Nigel A. Cunliffe

View Full Paper

Ask AI

Bookmark

Share

Abstract

Preview this article: Coronavirus disease (COVID-19) – impact on vaccine preventable diseases, Page 1 of 1 < Previous page | Next page > /docserver/preview/fulltext/eurosurveillance/25/18/eurosurv-25-18-6-1.gif

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hungerford et al. (2020) studied this question.

synapsesocial.com/papers/6ad870fff202b47796a3052a https://doi.org/10.2807/1560-7917.es.2020.25.18.2000756

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UKOriginal Research · 2018 · 99 citations
2Fatal encephalitis caused by Shamonda virus Europe 1 (SHAV-EU1) in a patient with a severely weakened immune system, France, 2026Eurosurveillance · 2026
3High levels of domestic transmission and drug resistance –analysis of national surveillance data for shigellosis, the Netherlands, 2018 to 2024Eurosurveillance · 2026
4Understanding vaccination against human papillomavirus (HPV): knowledge and perceptions among parents or guardians and healthcare workers, Germany, 2023Eurosurveillance · 2026
5Assessing the impact of the COVID-19 pandemic on routine childhood vaccination uptake, the Netherlands, 2016 to 2025Eurosurveillance · 2026

Changes in age composition and epidemiology of candidaemia, Iceland, 2012 to 2023Eurosurveillance · 2026
Timely evidence generation in epidemic response: lessons from an attempted analytical epidemiological investigation during an mpox outbreak, Ireland, 2022Eurosurveillance · 2026
Two incursions, two viruses: emergence of a second novel Shamonda virus clade, Germany, 2026Eurosurveillance · 2026
Trends and risk factors associated with hepatitis A severity and mortality in French hospitals: a national population-based study, 2013 to 2024Eurosurveillance · 2026
Increase in congenital syphilis in the European Union and European Economic Area, 2015 to 2024 – time to scale-up public health responsesEurosurveillance · 2026

More from Eurosurveillance

More from University of Liverpool